Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

NCT03332771 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

954

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sotagliflozin (SAR439954)
DRUG: Glimepiride
DRUG: Metformin
DRUG: Placebo
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]